ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

Fish Oil May Help Prevent Weight Loss In Cancer Patients

September 26, 2003

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

Ellen Stoval Calls For More Funding for All Cancer Research

June 6, 1997